Patent Assignment
Reel/Frame 017089/0420
Merger
Recorded: 2005-12-16
Pages: 15
Assignor
SUMITOMO PHARMACEUTICALS COMPANY, LTD.
Executed: 2005-10-01
Assignee
DAINIPPON SUMITOMO PHARMA CO., LTD.
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, JAPAN
Covered Properties
(73)
Imide Derivatives, and Compositions for Use Antipsychotic Agents
Patent:
4,745,117 →
Application:
06/844,528 →
Carbapenem Compound in Crystalline Form, and Its Production and Use
Patent:
4,888,344 →
Application:
07/079,470 →
Sustained Release Composition for Pharmaceutical Substances Comprising a Silicone Elastomer Carrier
Patent:
4,985,253 →
Application:
07/481,722 →
Heterocyclic Compounds and Their Production
Patent:
5,231,179 →
Application:
07/684,488 →
Novel Beta-Lactams and Their Production
Patent:
5,310,897 →
Application:
07/974,302 →
Imide Derivatives, and Their Production and Use
Patent:
5,532,372 →
Application:
08/113,320 →
Novel Beta-Lactams and Their Production
Patent:
5,424,422 →
Application:
08/197,712 →
Imide Derivatives, and Thier Production and Use
Patent:
5,780,632 →
Application:
08/634,738 →
Controlled Release Drug Formulation of Open End Cylindrical Rod Form
Patent:
5,851,547 →
Application:
08/762,847 →
Sustained Release Formulation
Patent:
5,922,356 →
Application:
08/947,463 →
Naphthyridine Derivatives
Patent:
5,843,957 →
Application:
08/978,146 →
Drug for Ameliorating Renal Function
Patent:
6,153,581 →
Application:
09/043,823 →
Method for Treating Acute Hepatic Failure
Patent:
6,017,884 →
Application:
09/068,750 →
Novel Semaphorin Z and Gene Encoding the Same
Patent:
6,576,441 →
Application:
09/077,940 →
Remedies for Eating Disturbance
Patent:
6,225,283 →
Application:
09/214,597 →
Novel Semaphorin Gene: Semaphorin Y
Patent:
6,566,094 →
Application:
09/254,594 →
Novel Semaphorin Gene: Semaphorin W
Patent:
6,902,730 →
Application:
09/284,180 →
Medicament for Hypothermia Treatment
Patent:
6,210,697 →
Application:
09/284,649 →
Novel Semaphorin Genes (I)
Patent:
6,436,669 →
Application:
09/308,179 →
Immunopotentiating Composition
Application:
09/424,078 →
Crystalline Amrubicin Hydrochloride
Patent:
6,376,469 →
Application:
09/555,066 →
6-Amino-8-Hydroxypurines
Patent:
6,329,381 →
Application:
09/555,292 →
Amide Derivative
Patent:
6,384,033 →
Application:
09/559,626 →
Oral Formulation Comprising Biguanide and an Organic Acid
Patent:
6,517,870 →
Application:
09/674,150 →
Stable Gene Preparations
Patent:
7,052,875 →
Application:
09/701,013 →
Controlled Release Preparations Having Multi-Layer Structure
Patent:
7,101,567 →
Application:
09/701,303 →
Tumor Antigen Peptides Originating in Cyclophilin B
Patent:
7,041,297 →
Application:
09/720,469 →
Preparations for Immunotherapy for Cancer Having Bacterial Somatic Constituent as the Active Ingredient
Patent:
7,534,443 →
Application:
09/743,750 →
Naphthyridine Derivatives
Patent:
6,420,381 →
Application:
09/762,599 →
Oxindole Derivative
Patent:
6,576,656 →
Application:
09/763,241 →
Bicyclic Pyrimidine Compounds and Therapeutic Use Thereof
Patent:
6,458,798 →
Application:
09/763,728 →
Long Time Drug-Sustained Release Preparation
Patent:
6,756,048 →
Application:
09/786,746 →
Method for Analyzing the Amount of Intraabdominal Adipose Tissue
Patent:
6,844,163 →
Application:
09/958,561 →
Hydroxamic Acid Derivative
Patent:
6,713,477 →
Application:
09/959,192 →
CYP2A6 Gene Judgment Methods
Patent:
6,660,478 →
Application:
09/959,433 →
Sustained-Release Drug Formulations for Implantation
Patent:
7,247,312 →
Application:
10/089,694 →
Method of Manufacturing Drug Granules, the Drug Granules and Pharmaceutical Preparation Containing the Drug Granules
Amide Derivative
Novel semaphorin genes (I)
Application:
10/144,031 →
Publication:
US 2002/0146775
Novel Anti-Autoimmune Composition by Inhibition of Grf Action
Application:
10/147,087 →
Publication:
US 2003/0013637
Tablets disintegrating rapidly in the oral cavity
Application:
10/187,963 →
Publication:
US 2003/0026835
Bicyclic Pyrimidine Compounds and Therapeutic Use Thereof
Gene Preparations
Novel Semaphorin gene: Semaphorin Y
Application:
10/300,834 →
Publication:
US 2003/0077669
Preparations for oligonucleotide transfer
Application:
10/311,621 →
Publication:
US 2004/0052840
Five-Membered-Ring Compound
Novel Remedies for Cancer
Remedies for Cisplatin-Tolerant Cancer
Pyrrole Derivatives
Oral Preparations with Favorable Disintegration Characteristics
Novel Semaphorin Z and Gene Encoding the Same
Transgenic animal expressing hla-a24 and utilization thereof
Application:
10/450,255 →
Publication:
US 2005/0050580
Medicament for treating lung cancer
1, 2-Dihydro-2-Oxo-1, 8-Naphthyridine Derivative
Method of promoting nucleic acid transfer
Freeze-Dried Pharmaceutical Preparation
Method for the treatment of fibrosis with pyrrole derivatives
Application:
10/502,933 →
Publication:
US 2005/0227978
Medicament for Treating Lung Cancer
Novel piperidine derivative
Application:
10/511,319 →
Publication:
US 2005/0165057
Indole Indazole and Benzazole Derivative
Bacterial Cell Wall Skeleton Component Preparation
Application:
10/522,877 →
Publication:
US 2005/0250175
Remedy for Integration Dysfunction Syndrome
Site-specific gene conversion promoter and gene therapeutic
Application:
10/527,597 →
Publication:
US 2006/0258602
Novel Adenine Compound and Use Thereof
Tumor Antigen Protein and Use Thereof
Freeze-Dried Preparation of Stabilized Anthracycline Compound
Novel Tumor Antigen Protein Sart-3 and Tumor Antigen Peptides Thereof
Pyrrole derivatives
Application:
10/840,746 →
Publication:
US 2004/0209939
Novel external agent
Application:
10/921,960 →
Publication:
US 2005/0158371
Novel Semaphorin gene: Semaphorin W
Application:
10/925,970 →
Publication:
US 2005/0249741
Five-Membered Cyclic Compounds
Tumor Antigen Peptides Derived from Cyclophilin B
Dna Containing Variant Frt Sequences
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
May 22, 1986
From: ISHIZUMI, KIKUO; ANTOKU, FUJIO; MARUYAMA, ISAMU; KOJIMA, ATUYUKI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 004567/0849 →
Assignment of Assignor's Interest
Nov 25, 1997
From: MURAOKA, MASAMI; IORIYA, KATSUHISA; OHASHI, NAOHITO; YAGI, HIDEKI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009120/0440 →
Assignment of Assignor's Interest
Dec 8, 1997
From: KOSEKI, NORIMASA; SANO, AKIHIKO
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED; KOKEN CO., LTD.
Reel/Frame 008837/0079 →
Assignment of Assignor's Interest
Mar 27, 1998
From: SANAKA, TSUTOMU
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009151/0244 →
Assignment of Assignor's Interest
May 15, 1998
From: ICHIDA, FUMIHIRO; MIYAGIWA, MIKI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009484/0916 →
Assignment of Assignor's Interest
Jun 5, 1998
From: KIMURA, TORU; KIKUCHI, KAORU
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009482/0244 →
Assignment of Assignor's Interest
Mar 3, 1999
From: HASHIZUME, KIYOSHI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009795/0818 →
Assignment of Assignor's Interest
Apr 16, 1999
From: HAYASHI, NARIYUKI
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009946/0783 →
Assignment of Assignor's Interest
May 11, 1999
From: KIMURA, TORU; KIKUCHI, KAORU
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 009945/0298 →
Assignment of Assignor's Interest
May 14, 1999
From: INAGAKI, SHINOBU; FURUYAMA, TATSUO
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 010077/0674 →
Assignment of Assignor's Interest
Jun 9, 1999
From: KIMURA, TORU; KIKUCHI, KAORU
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 010009/0070 →
Assignment of Assignor's Interest
Jan 19, 2000
From: FUJIOKA, KEIJI; SANO, AKIHIKO; NAGAHARA, SHUNJI; BRANDON, MALCOLM ROY
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED; MELBOURNE, UNIVERSITY OF, THE; KOKEN CO., LTD.
Reel/Frame 010533/0721 →
Assignment of Assignor's Interest
May 24, 2000
From: SHIMAGO, KOZO; UENISHI, YUKO
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 010867/0997 →
Assignment of Assignor's Interest
May 26, 2000
From: KURIMOTO, AYUMU; OGINO, TETSUHIRO; KAWAKAMI, HAJIME
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED; JAPAN ENERGY CORPORATION
Reel/Frame 011148/0774 →
Assignment of Assignor's Interest
Jul 27, 2000
From: IKEDA, KAZUHITO; TATSUNO, TOHRU; OGO, HIROKI; NISHIHARA, TOSHIO
To: SUMITOMO PHARMACEUTICALS COMPANY LIMITED
Reel/Frame 011002/0573 →
Assignment of Assignor's Interest
Oct 27, 2000
From: NISHII, HIROYUKI; KOBAYASHI, HIROHISA; OTODA, KAZUYA
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 011254/0850 →
Assignment of Assignor's Interest
Nov 28, 2000
From: SANO, AKIHIKO; KAJIHARA, MASAKO; SUGIE, TOSHIHIKO
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Reel/Frame 011439/0306 →
Assignment of Assignor's Interest
Jan 12, 2001
From: TERADA, MASAAKI; OCHIYA, TAKAHIRO; SANO, AKIHIKO; HISADA, AKIHIKO
To: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED; KOKEN CO., LTD.
Reel/Frame 011465/0757 →
Assignment of Assignor's Interest
May 9, 2006
From: JAPAN ENERGY CORPORATION
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017870/0570 →
Change of Address of Assignee
Jul 13, 2007
From: KOKEN CO., LTD.
To: KOKEN CO., LTD.
Reel/Frame 019558/0050 →
Assignment of Assignor's Interest
Nov 24, 2010
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: JCR PHARMACEUTICALS CO., LTD.
Reel/Frame 025421/0215 →
Change of Name
Oct 7, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033905/0778 →
Change of Name
Oct 17, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034014/0418 →